financetom
Business
financetom
/
Business
/
Kiska Brand Bajega: Here's the success story of India's most iconic soft drink brand 'Rasna'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kiska Brand Bajega: Here's the success story of India's most iconic soft drink brand 'Rasna'
Apr 16, 2021 2:17 PM

On the new series of 'Kiska Brand Bajega - Industry Titans', Aditya Bhat speaks to the biggest intellectual minds behind some of India's biggest brands.

In today's edition, Aditya uncovers the story of India's most iconic soft drink concentrate brand, a brand with a golden legacy that spread love to billions of families, making them truly a household name.

Rasna's marketing campaigns like "I Love You Rasna", "Rasna Girl" and "Life Mein Rasna Milaofy" became their brand identifies and with their affordable pricing strategy soon made them a mass brand that struck the perfect cord with all kinds of consumers.

Watch the success story of Rasna with Chairman & MD Piruz Khambatta.

(Edited by : Bivekananda Biswas)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FTC to delay decision on Chevron-Hess deal during Exxon arbitration, Bloomberg reports
US FTC to delay decision on Chevron-Hess deal during Exxon arbitration, Bloomberg reports
Jul 11, 2024
(Reuters) - The U.S. Federal Trade Commission plans to delay its decision whether to block Chevron's $53 billion takeover of Hess until after an arbitration case with Exxon Mobil is settled, Bloomberg News reported on Thursday. The signal from the U.S. regulator is another hurdle for Chevron's proposed acquisition of Hess. The deal, which was initially planned to close in...
Kane Biotech Signs a License Agreement with Omni Bioceutical For Its Scalp Care Products
Kane Biotech Signs a License Agreement with Omni Bioceutical For Its Scalp Care Products
Jul 11, 2024
12:37 PM EDT, 07/11/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it signed a worldwide license agreement with Arizona-based Omni Bioceutical Innovations for its coactiv+ line of scalp care products. The five-year non-exclusive agreement will see Omni commercialize Kane's scalp-detoxifier product under the Omni Bioceuticals brand in the medical aesthetics market. Kane's scalp-care product line addresses...
Senator wants Boeing CEO to testify as she prepares new FAA legislation
Senator wants Boeing CEO to testify as she prepares new FAA legislation
Jul 11, 2024
WASHINGTON, July 11 (Reuters) - U.S. Senate Commerce Committee chair Maria Cantwell said Thursday she wants Boeing ( BA ) CEO Dave Calhoun to appear before her committee as she prepares legislation that would boost Federal Aviation Administration oversight of planemakers. Calhoun appeared before another Senate committee on June 19, but Cantwell told reporters Thursday she expects the outgoing chief...
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
Jul 11, 2024
Biodexa Pharmaceuticals PLC ( BDRX ) announced progress on eRapa, its drug to treat Familial Adenomatous Polyposis (FAP), an inherited disorder characterized by cancer of the large intestine (colon) and rectum. 12-month data from a phase 2 clinical trial were recently presented at the 2024 InSIGHT biannual meeting. With FAP, hundreds or thousands of precancerous polyps grow throughout the gastrointestinal tract....
Copyright 2023-2026 - www.financetom.com All Rights Reserved